Global Thyroid Gland Disorder Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave’s disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the globe and is measured as a prime risk factor for the increase in prevalence of thyroid disorders.



Scope of the Report:

This report studies the Thyroid Gland Disorder Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Thyroid Gland Disorder Treatment market by product type and applications/end industries.

The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder. However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period.

One of the primary drivers for the market growth is the escalating patient population with iodine deficiency. Iodine deficiency is predominant around the globe when compared with the large consumers of iodine and is particularly seen in pregnant women and young children. Iodine is present in the body in minute amounts, mainly in the thyroid gland and has a significant role to play in the thyroid synthesis.  It has been observed that over two billion individuals have insufficient iodine intake, among which South Asia and sub-Saharan Africa are majorly affected. The introduction of various remedies for the treatment of this deficiency will boost market growth in the coming years.

The global Thyroid Gland Disorder Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Thyroid Gland Disorder Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

Abbott

bioMérieux

Danaher

DiaSorin

Siemens Healthineers



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Hyperthyroidism

Hypothyroidism

Others



Market Segment by Applications, can be divided into

Men

Women

Frequently Asked Questions